Compare Divis Laboratories with Dishman Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs DISHMAN PHARMA - Comparison Results

DIVIS LABORATORIES     Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES DISHMAN PHARMA DIVIS LABORATORIES/
DISHMAN PHARMA
 
P/E (TTM) x 32.6 25.1 130.0% View Chart
P/BV x 7.4 3.3 219.7% View Chart
Dividend Yield % 0.6 0.7 91.8%  

Financials

 DIVIS LABORATORIES   DISHMAN PHARMA
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-18
DISHMAN PHARMA
Mar-16
DIVIS LABORATORIES/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs1,142374 305.0%   
Low Rs533129 413.6%   
Sales per share (Unadj.) Rs146.6197.8 74.1%  
Earnings per share (Unadj.) Rs33.021.2 155.8%  
Cash flow per share (Unadj.) Rs38.434.7 110.6%  
Dividends per share (Unadj.) Rs10.002.00 500.0%  
Dividend yield (eoy) %1.20.8 150.2%  
Book value per share (Unadj.) Rs222.8179.9 123.9%  
Shares outstanding (eoy) m265.4780.69 329.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x5.71.3 449.0%   
Avg P/E ratio x25.311.9 213.6%  
P/CF ratio (eoy) x21.87.2 300.9%  
Price / Book Value ratio x3.81.4 268.7%  
Dividend payout %30.39.4 320.9%   
Avg Mkt Cap Rs m222,31820,306 1,094.9%   
No. of employees `00010.80.8 1,298.2%   
Total wages/salary Rs m4,5615,355 85.2%   
Avg. sales/employee Rs Th3,616.019,252.7 18.8%   
Avg. wages/employee Rs Th423.86,459.5 6.6%   
Avg. net profit/employee Rs Th814.92,064.1 39.5%   
INCOME DATA
Net Sales Rs m38,91515,961 243.8%  
Other income Rs m1,134265 427.4%   
Total revenues Rs m40,04916,226 246.8%   
Gross profit Rs m12,6174,103 307.5%  
Depreciation Rs m1,4251,091 130.7%   
Interest Rs m13944 1.4%   
Profit before tax Rs m12,3132,334 527.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,543624 568.2%   
Profit after tax Rs m8,7701,711 512.5%  
Gross profit margin %32.425.7 126.1%  
Effective tax rate %28.826.7 107.7%   
Net profit margin %22.510.7 210.2%  
BALANCE SHEET DATA
Current assets Rs m45,35111,018 411.6%   
Current liabilities Rs m6,5079,517 68.4%   
Net working cap to sales %99.89.4 1,061.5%  
Current ratio x7.01.2 602.0%  
Inventory Days Days127110 114.7%  
Debtors Days Days9535 273.1%  
Net fixed assets Rs m21,16016,304 129.8%   
Share capital Rs m531161 328.9%   
"Free" reserves Rs m58,62512,907 454.2%   
Net worth Rs m59,15614,516 407.5%   
Long term debt Rs m04,189 0.0%   
Total assets Rs m67,83229,805 227.6%  
Interest coverage x926.83.5 26,701.7%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x0.60.5 107.1%   
Return on assets %12.98.9 145.3%  
Return on equity %14.811.8 125.8%  
Return on capital %20.817.5 118.9%  
Exports to sales %024.8 0.0%   
Imports to sales %21.83.7 583.6%   
Exports (fob) Rs mNA3,956 0.0%   
Imports (cif) Rs m8,485596 1,423.0%   
Fx inflow Rs m32,3594,952 653.5%   
Fx outflow Rs m9,042697 1,297.7%   
Net fx Rs m23,3174,255 548.0%   
CASH FLOW
From Operations Rs m7,7592,786 278.4%  
From Investments Rs m-4,783-1,529 312.8%  
From Financial Activity Rs m-3,142-941 333.8%  
Net Cashflow Rs m-166316 -52.5%  

Share Holding

Indian Promoters % 52.0 61.4 84.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 11.8 3.7 318.9%  
FIIs % 19.0 12.7 149.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.2 22.1 77.8%  
Shareholders   31,796 46,261 68.7%  
Pledged promoter(s) holding % 0.0 35.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   DR. REDDYS LAB  IPCA LABS  JUBILANT LIFE SCIENCES  SUN PHARMA  PIRAMAL ENTERPRISES  

Compare DIVIS LABORATORIES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex's Journey From 640 Points Down to 2,000 Points Up(Podcast)

What a week it was! While crude oil prices dragged the Indian stock markets lower, finance minister Nirmala Sitharaman's boosters sent markets soaring and how!

Related Views on News

DIVIS LABORATORIES Announces Quarterly Results (1QFY20); Net Profit Up 0.4% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, DIVIS LABORATORIES has posted a net profit of Rs 3 bn (up 0.4% YoY). Sales on the other hand came in at Rs 11 bn (up 14.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (4QFY19); Net Profit Up 10.6% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, DIVIS LABORATORIES has posted a net profit of Rs 3 bn (up 10.6% YoY). Sales on the other hand came in at Rs 13 bn (up 15.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (3QFY19); Net Profit Up 68.9% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DIVIS LABORATORIES has posted a net profit of Rs 4 bn (up 68.9% YoY). Sales on the other hand came in at Rs 13 bn (up 29.4% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES 2017-18 Annual Report Analysis (Annual Result Update)

Jan 1, 2019 | Updated on Jan 1, 2019

Here's an analysis of the annual report of DIVIS LABORATORIES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

DIVIS LABORATORIES Announces Quarterly Results (2QFY19); Net Profit Up 92.3% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, DIVIS LABORATORIES has posted a net profit of Rs 4 bn (up 92.3% YoY). Sales on the other hand came in at Rs 13 bn (up 44.3% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

DIVIS LABORATORIES SHARE PRICE


Sep 20, 2019 (Close)

TRACK DIVIS LABORATORIES

  • Track your investment in DIVIS LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DIVIS LABORATORIES

DIVIS LABORATORIES 8-QTR ANALYSIS

COMPARE DIVIS LABORATORIES WITH

MARKET STATS